Johnson M
Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
PreprintPsilocybin
Neural correlates and behavioral outcomes of aesthetic chills and their prosthetic augmentation
PreprintPsilocybin
Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST in individuals with anxiety and depression
ArticleDMT
Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression: A Phase 2a Open-Label Clinical Trial.
ArticlePsilocybin
Retail Availability of Intoxicating Cannabis and Mushroom Products Across Eleven U.S. Cities: Sales Persist Despite Prohibitions.
ArticlePsilocybin
Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.
PreprintPsychedelics
Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample
PreprintPsilocybin
Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST
ArticlePsychedelics
Exploring self-reported health behavior change following naturalistic psychedelic use.
ArticlePsychedelics
On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS).
PreprintPsilocybin
Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use
PreprintPsilocybin